[Experimental study of L 5818 Labaz used as a vasocontrictor in nasal instillation].
D000281:Administration, Intranasal; D000328:Adult; D000818:Animals; D001572:Benzofurans / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D055598:Chemical Phenomena; D002621:Chemistry; D002923:Cilia / Q000187:drug effects; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D014663:Nasal Decongestants / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D009297:Nasal Mucosa / Q000166:cytology / Q000187:drug effects*; D051381:Rats; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy; D014655:Vascular Resistance / Q000187:drug effects
D001572:Benzofurans; D007093:Imidazoles; D014663:Nasal Decongestants; C007141:coumazoline
Etude expérimentale du L 5818 Labaz, utilisé comme vasoconstricteur en instillation nasale